Thus, stimulation of FA transport by targeting SAT endothelium through Angpt2–integrin α5β1 signaling offers a new therapeutic avenue for combat against ectopic lipid-induced insulin resistance and related metabolic syndrome. This evidence concerns the gene ANGPT2 and Insulin resistance.